Oral versus parenteral administration of methotrexate for the treatment of active RA

Affiliations

Comment

Derrick J Todd et al. Nat Clin Pract Rheumatol. 2008 Jul.

. 2008 Jul;4(7):342-3.

doi: 10.1038/ncprheum0827. Epub 2008 Jun 3.

¹ Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA.

No abstract available

Comment on

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
Braun J, Kästner P, Flaxenberg P, Währisch J, Hanke P, Demary W, von Hinüber U, Rockwitz K, Heitz W, Pichlmeier U, Guimbal-Schmolck C, Brandt A; MC-MTX.6/RH Study Group. Braun J, et al. Arthritis Rheum. 2008 Jan;58(1):73-81. doi: 10.1002/art.23144. Arthritis Rheum. 2008. PMID: 18163521 Clinical Trial.